The £3 million Tumour Profiling Unit (TPU) in London is to research the use of DNA mapping to identify patients' cancer strains. It is hoped the technique will pave the way for radical new forms of diagnosis, surveillance and targeted therapy.
One aim of the research is to develop "liquid biopsies" that search for free-floating cancer DNA in samples of blood. This can then be used to identify and monitor cancer sub-types that are likely to respond to particular drugs.
Another, controversial, proposal is the use of "mouse avatars" that mirror a patient's disease progression.
Tumour samples from patients will be implanted into mice which will then be observed closely to spot early signs of molecular change and resistance to therapy.
More top news
More deprived areas of England have received the biggest cuts over the last five years, according to an influential think-tank.
A suspected burglar and domestic abuser who goaded police on their own Facebook page has been taunted back after handing himself in.
Motorists are to be allowed 10 minutes' grace after a parking ticket runs out before they can receive a fine, under new rules.